Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers
Administered By
Awarded By
Contributors
- Crosby, Erika J Investigator
- Hartman, Zachary Conrad Principal Investigator
- Lyerly, Herbert Kim Collaborator
- Troy, Jesse David Investigator
Start/End
- December 6, 2019 - November 30, 2024